From the Journals

A Smart Speaker for Diabetes Care?

Randomized trial links a voice-based virtual assistant to reduced distress and modest HbA1c improvements in older adults with type 2 diabetes

Share

  • 1

    IVAM-ED trial studied voice assistants for diabetes management.

  • 2

    112 older adults participated, aged 65+.

  • 3

    Intervention improved mental distress and glycemic control.

  • 4

    HbA1c decreased by ~0.5% in the intervention group.

  • 5

    Enhanced quality of life and diabetes self-care were reported.

  • 6

    Open-label design and short follow-up limited generalizability.

  • 7

    Participants had access to a smart speaker for support.

Original Source(s)

A Smart Speaker for Diabetes Care?

Randomized trial links a voice-based virtual assistant to reduced distress and modest HbA1c improvements in older adults with type 2 diabetes

  • by Jess Allerton

  • March 2, 2026

  • 2 min

Related Content

AI and Diabetes: Promise and Precaution

The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

Retrospective study finds machine-learning model identifies clinical factors associated with preterm delivery in a high-risk obstetric population.

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.